SGK
SOLV icon

Steigerwald Gordon & Koch’s Solventum SOLV Stock Holding History

Steigerwald Gordon & Koch’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34
Closed -$2.69K – 891
2025
Q4 		$2.69K Hold
34
– – ﹤0.01% 776
2025
Q3 		$2.48K Buy
+34
New +$2.49K ﹤0.01% 707

Other funds holding SOLV

IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Steigerwald Gordon & Koch's SOLV Position: Q1 2026 in Review

Steigerwald Gordon & Koch sold out of Solventum (SOLV) in Q1 2026, closing a stake of 34 shares — an estimated $2.69K sold.

Steigerwald Gordon & Koch first reported a position in SOLV in Q3 2025 and held it in 2 quarters. The position peaked at $2.69K in Q4 2025. 881 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Steigerwald Gordon & Koch reported no remaining Solventum position as of Q1 2026 after selling out during the quarter.
  • Steigerwald Gordon & Koch sold 34 Solventum shares in Q1 2026, an estimated $2.69K.
  • Steigerwald Gordon & Koch first reported a position in Solventum in Q3 2025 and held it in 2 quarters.
  • Steigerwald Gordon & Koch's Solventum position peaked at $2.69K in Q4 2025.
  • 881 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q1 2026, filed 28 Apr 2026.